Patient Derived Xenograft or PDX Models Market - Global Professional Analysis and Forecast to 2026
- REPORT SUMMARY
- TABLE OF CONTENTS
- INDUSTRY COVERAGE
The worldwide Patient Derived Xenograft or PDX Models market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.3% during the forecast period.
This report presents the market size and development trends by detailing the Patient Derived Xenograft or PDX Models market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Patient Derived Xenograft or PDX Models market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Patient Derived Xenograft or PDX Models industry and will help you to build a panoramic view of the industrial development.
Patient Derived Xenograft or PDX Models Market, By Type:
Mice Models
Rat Models
Patient Derived Xenograft or PDX Models Market, By Application:
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Academic & Research Institutions
Some of the leading players are as follows:
Xentech
Champions Oncology Inc.
Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
Urolead
Shanghai Lide Biotech Co. Ltd. (China)
Hera Biolabs
Charles River Laboratories International Inc.
Epo Berlin-Buch Gmbh
Pharmatest Services Ltd.
Crown Bioscience Inc.
Xenopat (Spain)
Oncodesign
Horizon Discovery Group Plc (Sage Labs Inc.)
The Jackson Laboratory
Bioduro (Us)
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Patient Derived Xenograft or PDX Models Market: Technology Type Analysis
-
4.1 Patient Derived Xenograft or PDX Models Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Patient Derived Xenograft or PDX Models Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Mice Models
4.3.2 Rat Models
5 Patient Derived Xenograft or PDX Models Market: Product Analysis
-
5.1 Patient Derived Xenograft or PDX Models Product Market Share Analysis, 2018 & 2026
-
5.2 Patient Derived Xenograft or PDX Models Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Patient Derived Xenograft or PDX Models Market: Application Analysis
-
6.1 Patient Derived Xenograft or PDX Models Application Market Share Analysis, 2018 & 2026
-
6.2 Patient Derived Xenograft or PDX Models Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Pharmaceutical & Biotechnology Companies
6.3.2 Contract Research Organizations
6.3.3 Academic & Research Institutions
7 Patient Derived Xenograft or PDX Models Market: Regional Analysis
-
7.1 Patient Derived Xenograft or PDX Models Regional Market Share Analysis, 2018 & 2026
-
7.2 Patient Derived Xenograft or PDX Models Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Xentech
9.1.1 Xentech Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Champions Oncology Inc.
9.2.1 Champions Oncology Inc. Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec)
9.3.1 Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec) Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Urolead
9.4.1 Urolead Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Shanghai Lide Biotech Co. Ltd. (China)
9.5.1 Shanghai Lide Biotech Co. Ltd. (China) Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Hera Biolabs
9.6.1 Hera Biolabs Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Charles River Laboratories International Inc.
9.7.1 Charles River Laboratories International Inc. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Epo Berlin-Buch Gmbh
9.8.1 Epo Berlin-Buch Gmbh Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Pharmatest Services Ltd.
9.9.1 Pharmatest Services Ltd. Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Crown Bioscience Inc.
9.10.1 Crown Bioscience Inc. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Xenopat (Spain)
9.11.1 Xenopat (Spain) Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Oncodesign
9.12.1 Oncodesign Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Horizon Discovery Group Plc (Sage Labs Inc.)
9.13.1 Horizon Discovery Group Plc (Sage Labs Inc.) Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 The Jackson Laboratory
9.14.1 The Jackson Laboratory Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Bioduro (Us)
9.15.1 Bioduro (Us) Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
The List of Tables and Figures (Totals 81 Figures and 140 Tables)
Figure Mice Models Patient Derived Xenograft or PDX Models market, 2015 - 2026 (USD Million)
Figure Rat Models Patient Derived Xenograft or PDX Models market, 2015 - 2026 (USD Million)
Figure Pharmaceutical & Biotechnology Companies market, 2015 - 2026 (USD Million)
Figure Contract Research Organizations market, 2015 - 2026 (USD Million)
Figure Academic & Research Institutions market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Patient Derived Xenograft or PDX Models market, by country, 2015 - 2026 (USD Million)
-
Table North America Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table North America Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table North America Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Canada Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Canada Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Europe Patient Derived Xenograft or PDX Models market, by country, 2015 - 2026 (USD Million)
-
Table Europe Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Europe Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Europe Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Germany Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Germany Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table France Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table France Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Italy Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Italy Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Spain Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Spain Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Patient Derived Xenograft or PDX Models market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table China Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table China Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Japan Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Japan Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table India Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table India Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Patient Derived Xenograft or PDX Models market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table MEA Patient Derived Xenograft or PDX Models market, by country, 2015 - 2026 (USD Million)
-
Table MEA Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table MEA Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table MEA Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Patient Derived Xenograft or PDX Models market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Patient Derived Xenograft or PDX Models market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Patient Derived Xenograft or PDX Models market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Xentech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Champions Oncology Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Wuxi Apptec (Group of Subsidiaries Under Wuxi Pharmatec) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Urolead Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Shanghai Lide Biotech Co. Ltd. (China) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Hera Biolabs Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Charles River Laboratories International Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Epo Berlin-Buch Gmbh Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pharmatest Services Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Crown Bioscience Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Xenopat (Spain) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Oncodesign Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Horizon Discovery Group Plc (Sage Labs Inc.) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table The Jackson Laboratory Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bioduro (Us) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Report Purchase
